Skip to main content
Erschienen in: Journal of Cancer Survivorship 5/2018

Open Access 30.07.2018

Factors influencing job loss and early retirement in working men with prostate cancer—findings from the population-based Life After Prostate Cancer Diagnosis (LAPCD) study

verfasst von: Damien Bennett, Therese Kearney, David W. Donnelly, Amy Downing, Penny Wright, Sarah Wilding, Richard Wagland, Eila Watson, Adam Glaser, Anna Gavin

Erschienen in: Journal of Cancer Survivorship | Ausgabe 5/2018

Abstract

Purpose

To investigate factors associated with job loss and early retirement in men diagnosed with prostate cancer (PCa) 18–42 months previously.

Methods

Men ≤ 60 years at diagnosis who completed the Life After Prostate Cancer Diagnosis (LAPCD) survey were identified. Men who moved from employment at diagnosis to unemployment (EtoU) or retirement (EtoR) at survey (18–42 months post-diagnosis) were compared to men remaining in employment (EtoE). Sociodemographic, clinical and patient-reported factors were analysed in univariable and multivariable analysis.

Results

There were 3218 men (81.4%) in the EtoE, 245 (6.2%) in EtoU and 450 (11.4%) in the EtoR groups. Men with stage IV disease (OR = 4.7 95% CI 3.1–7.0, relative to stage I/II) and reporting moderate/big bowel (OR = 2.5, 95% CI 1.6–3.9) or urinary problems (OR = 2.0, 95% CI 1.4–3.0) had greater odds of becoming unemployed. Other clinical (≥ 1 comorbidities, symptomatic at diagnosis) and sociodemographic (higher deprivation, divorced/separated), living in Scotland or Northern Ireland (NI)) factors were predictors of becoming unemployed. Men who were older, from NI, with stage IV disease and with caring responsibilities had greater odds of retiring early. Self-employed and non-white men had lesser odds of retiring early.

Conclusion

PCa survivors who retire early following diagnosis do not report worse urinary or bowel problems compared to men remaining in employment. However, we identified clinical and sociodemographic factors which increased unemployment risk in PCa survivors.

Implications for Cancer Survivors

Targeted support and engagement with PCa survivors at risk of unemployment, including their families and employers, is needed.
Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s11764-018-0704-x) contains supplementary material, which is available to authorized users.
Adam Glaser and Anna Gavin are joint senior authors

Background

As the diagnosis, treatment and survival of most cancers have improved, the number of cancer survivors has increased, with this trend set to continue [1]. Prostate cancer (PCa) survivors account for a large proportion of these, with 30% of UK cancer survivors living with the disease [2]. Although PCa incidence is more common in older men, approximately 30% of UK survivors are of working age and the effect of cancer and its treatment can adversely impact working life and employment status [3, 4]. Indeed, a UK study found the greatest increase in PCa incidence rates between 2000 and 2010 was in men under 60 years of age [5].
Recently, there has been increased focus on workers diagnosed with cancer to ensure that appropriate assistance and information is given to support decisions about work and personal finances [6]. Work can be important for men recovering from cancer as it allows them support themselves and their families, socialise with colleagues and regain a sense of normality which can help them to ‘move on’ [7, 8]. Studies of risk factors for job loss in PCa survivors have involved small numbers of PCa survivors and usually been part of larger cancer cohorts from Nordic countries, the USA or Australia [9]. Although previous studies describe demographic, clinical and work-related characteristics associated with work ability, employment status and return to work for cancer survivors across a range of tumour sites, variable findings have been reported and few focus specifically on PCa survivors [9]. A study which reported on 100 PCa survivors in Ireland 6–24 months post-diagnosis found those who were self-employed had lower household income and did not have surgery were more likely to continue working following diagnosis, while those with lower educational level, medical card entitlement (providing free access to public health services) and not receiving sick pay were more likely not to resume work following diagnosis [10]. However, the effect of recent diagnosis of PCa on subsequent employment, and particularly unemployment and early retirement, have not been previously reported in a large-scale study. This study aimed to identify factors associated with movement from employment to unemployment or early retirement in working age men diagnosed with PCa in the UK.

Methods

Data were collected as part of the UK-wide Life After Prostate Cancer Diagnosis (LAPCD) study. The study design has been reported elsewhere [11]. PCa survivors between 18 and 42 months following first diagnosis were identified from population-based cancer registries in England, Wales and Northern Ireland (NI) and from hospital activity data in Scotland. A postal questionnaire was sent to 58,930 men. Respondents answered questions on functional outcomes and personal and sociodemographic characteristics and other measures including health-related quality of life (HRQL), social difficulties, decision regret and emotional well-being.
Men aged 60 years and younger at time of diagnosis who completed a questionnaire were included in this study. The UK state pension age for men at the time of survey (October 2015 to November 2016) was 65 years [12] and the average age of men withdrawing from the labour market was just below 65 years (64.6 years) [13]. Consequently, we used a practical threshold of 60 years and below at diagnosis for inclusion. Although it is difficult to define early retirement, men aged 60 years and below at diagnosis would have been aged up to 63.5 years when they participated in LAPCD (18–42 months later), below the UK male state pension age. In the UK, currently only 22% of men aged 60 and below have retired suggesting this as a reasonable cutoff [13].
Responses to questions about employment status at time of cancer diagnosis and time of survey were used to categorise men as moving from employment to unemployment (EtoU), from employment to retirement (EtoR) or remaining in employment (EtoE) (Survey in Supplementary File 1). Those who chose ‘full time employment’ (FTE), ‘part time employment’ (PTE) or ‘self-employed’ (SE) were categorised as ‘employed’ while those who chose ‘unemployed, seeking work’ or ‘unemployed, unable to work for health reasons’ were categorised as ‘unemployed’ and those who chose ‘retired’ were classified as such. Those who recorded ‘looking after family/home’ and ‘other’ were excluded from analysis as focus was on movement between employed and unemployed and retired states and it would be difficult to clearly delineate a change in status between these states and the unemployed or retired state.

Clinical characteristics, sociodemographic factors and patient-reported symptoms

Stage and age at diagnosis and UK nation of residence were determined from cancer registration data. Deprivation levels were determined from UK Indices of Multiple Deprivation (IMD) derived from patients’ home postcode at diagnosis [1417]. Respondents’ self-reported employment status; relationship status; ethnicity; height and weight (from which BMI was derived [18]); whether they had carer responsibilities; whether they had ever seen a healthcare professional for problems with emotions; nerves or use of alcohol or drugs; treatment type; comorbidities (total number of long-term conditions (LTCs), e.g. stroke, diabetes) and overall urinary and bowel function (from the Expanded Prostate Cancer Index Composite short form (EPIC-26) questions ‘How big a problem has your urinary/bowel function been for you during the last 4 weeks?’ [19] were taken from the survey data (Supplementary File 1).

Statistical analysis

Univariable analyses were undertaken to assess differences in sociodemographic and clinical characteristics between both the EtoU and EtoR groups and the EtoE group. Differences in categorical variables were assessed using Chi-squared tests and continuous variables using t tests. Bonferroni correction was used to compensate for multiple comparisons. Variables were entered as predictors in regression analysis using a univariable analysis cutoff of p < 0.2 or if they were of a priori importance (e.g., age, patient-reported symptoms). Treatment type (surgery, radiotherapy, etc.) was not included in regression analysis. Certain treatments are more likely to lead to specific function problems (e.g., surgery is associated with worse urinary function) and it is the effect of resulting symptoms that is of interest. Multivariable logistic regression (backwards stepwise) analyses was performed with outcome variables being change in employment status from EtoU and from EtoR with the reference category being no change in employment status (i.e. EtoE). Data were analysed with SPSS Version 22.0 (IBM Corp, Armonk, NY).

Results

Of the 58,930 men invited to participate, 35,823 returned completed questionnaires (60.8% response rate);14.1% (N = 5037/35,823) of respondents were ≤ 60 years at PCa diagnosis. Non-response on employment status was low: 1.5% (75/5037) did not respond on employment status at diagnosis, 2.2% (N = 109) did not respond on employment status at time of survey and 3.1% (N = 155) did not respond on both. Non-responders were more likely to be divorced, living in areas of greater deprivation, of non-white ethnicity and report overall urinary problems. Supplementary Table 1 details the characteristics of employment status respondents and non-respondents.
Employment status and change in employment status between time of diagnosis and time of survey are shown in Table 1. Of those aged ≤ 60 years at diagnosis, 4014 were employed at diagnosis and 3913 of these were employed, unemployed or retired at survey. Of these 3913 men, there were 3218 (81.4%) in the EtoE group, 245 (6.2%) in the EtoU group and 450 (11.4%) in the EtoR group (Fig. 1). Table 2 details the characteristics, treatment and patient-reported symptoms variables in the three groups.
Table 1
Employment status at time of diagnosis and survey, and change in status, for men aged 60 years old and less at time of diagnosis
 
Employed
Retired
Unemployed
Home
Other
Total
Missing
At diagnosis
80.9%
10.4%
7.1%
0.8%
0.8%
100%
 
(4014)
(516)
(351)
(42)
(39)
(4962)
75
At survey
66.7%
19.8%
11.3%
0.8%
1.3%
100%
 
(3289)
(977)
(559)
(40)
(63)
(4928)
109
 
Employed to employed (EtoE)
Employed to retired (EtoR)
Employed to unemployed (EtoU)
Employed to home (EtoH)
Employed to other (EtoO)
Total
Missing
Change in employment status between diagnosis and survey
% (number)
81.4%
11.4%
6.2%
0.3%
0.8%
100%
 
(3218)
(450)
(245)
(10)
(32)
(3955)
59
Table 2
Sociodemographic, clinician and patient-reported urinary and bowel symptoms for EtoE, EtoU and EtoR groups for men aged 60 years and below
Variable
Employed to employed (EtoE)
Employed to unemployed (EtoU)
p value (comparing EtoE and EtoU)
Total
Employed to retired (EtoR)
p value (comparing EtoE and EtoR)
Total
Mean age (years) [SD]
55.4 [3.8]
55.9 [3.5]
0.03 (t test)
 
57.7 [2.5]
< 0.001* (t test)
 
Age bands
  
0.290
  
< 0.001*
 
≤ 50 years
11.0% (353)
8.2% (20)
 
10.8% (373)
1.6% (7)
 
9.8% (360)
51–55
33.2% (1067)
31.8% (78)
 
33.1% (1145)
15.3% (69)
 
31.0% (1136)
56–60
55.9% (1798)
60.0% (147)
 
56.2% (1945)
83.1% (374)
 
59.2% (2172)
Total
100% (3218)
100% (245)
 
100% (3463)
100% (450)
 
100% (3668)
Marital status
  
< 0.001*
  
0.036
 
Married/civil partnership
80.9% (2598)
68.3% (166)
 
80.0% (2764)
81.1% (365)
 
80.9% (2963)
Divorced/separated
10.1% (324)
19.8% (48)
 
10.8% (372)
8.0% (36)
 
9.8% (360)
Widowed
1.5% (47)
1.6% (4)
 
1.5% (51)
2.7% (12)
 
1.6% (59)
Single
4.7% (152)
7.0% (17)
 
4.9% (169)
6.7% (30)
 
5.0% (182)
Other
2.8% (90)
3.3% (8)
 
2.8% (98)
1.6% (7)
 
2.6% (97)
Total
100% (3211)
100% (243)
 
100% (3454)
100% (450)
 
100% (3661)
Deprivation
  
< 0.001*
  
0.009
 
Q1 (Area of least deprivation)
27.9% (876)
16.3% (39)
 
27.0% (915)
33.9% (151)
 
28.6% (1027)
Q2
26.2% (825)
19.2% (46)
 
25.7% (871)
26.5% (118)
 
26.3% (943)
Q3
18.7% (587)
18.8% (45)
 
18.7% (632)
19.1% (85)
 
18.7% (672)
Q4
16.0 (503)
21.3% (51)
 
16.4% (554)
13.9% (62)
 
15.7% (565)
Q5 (area of greatest deprivation)
11.3% (354)
24.6% (59)
 
12.2% (413)
6.7% (30)
 
10.7% (384)
Total
100% (3145)
100% (240)
 
100% (3385)
100% (446)
 
100% (3591)
UK country of residence
  
< 0.001*
  
0.003
 
England
85.3% (2744)
75.9% (186)
 
84.6% (2930)
81.6% (367)
 
84.8% (3111)
Wales
7.0% (225)
6.5% (16)
 
7.0% (241)
8.9% (40)
 
7.2% (265)
Scotland
4.5% (146)
9.8% (24)
 
4.9% (170)
3.3% (15)
 
4.4% (161)
Northern Ireland
3.2% (103)
7.8% (19)
 
3.5% (122)
6.2% (28)
 
3.6% (131)
Total
100% (3218)
100% (245)
 
100% (3463)
100% (450)
 
100% (3668)
Ethnicity
  
0.794
  
< 0.001*
 
White
92.6% (2938)
93.3% (223)
 
92.7% (3161)
97.5% (434)
 
93.2% (3372)
Non-white
7.4% (234)
6.7% (16)
 
7.3% (250)
2.5% (11)
 
6.8% (245)
Total
100% (3172)
100% (239)
 
100% (3411)
100% (445)
 
100% (3617)
Stage at diagnosis
  
< 0.001*
  
0.053
 
I/II
72.2% (2020)
50.5% (105)
 
70.7% (2125)
69.5% (267)
 
72.2% (2020)
III
20.9% (584)
23.6% (49)
 
21.1% (633)
20.1% (77)
 
20.8% (661)
IV
7.0% (195)
26.0% (54)
 
8.3% (249)
10.4% (40)
 
7.4% (235)
Total
100% (2799)
100% (208)
 
100% (3007)
100% (384)
 
100% (3183)
Treatment type
  
< 0.001*
  
0.071
 
Active surveillance and watchful waiting
16.1% (517)
4.5% (11)
 
15.3% (528)
15.8% (71)
 
16.0% (588)
Surgery
41.5% (1336)
25.7% (63)
 
40.4% (1399)
35.3% (159)
 
40.8% (1495)
ERBT
2.5% (81)
4.1% (10)
 
2.6% (91)
2.2% (10)
 
2.5% (91)
Brachytherapy
6.9% (221)
4.9% (12)
 
6.7% (233)
7.6% (34)
 
7.0% (255)
ADT
1.3% (42)
3.7% (9)
 
1.5% (51)
2.9% (13)
 
1.5% (55)
EBRT + ADT
9.9% (318)
16.3% (40)
 
10.3% (358)
12.4% (56)
 
10.2% (374)
Surgery + EBRT/ADT
8.2% (265)
9.4% (23)
 
8.3% (288)
8.9% (40)
 
8.3% (305)
ADT + systemic treatment
1.0% (32)
4.1% (10)
 
1.2% (42)
1.8% (8)
 
1.1% (40)
EBRT + systemic treatment
1.4% (45)
6.1% (15)
 
1.7% (60)
1.6% (7)
 
1.4% (52)
Other
11.2% (360)
21.2% (52)
 
11.9% (412)
11.6% (52)
 
11.2% (412)
Total
100% (3217)
100% (245)
 
100% (3462)
100% (450)
 
100% (3667)
Comorbidities
  
< 0.001*
  
0.003*
 
None
47.7% (1536)
27.3% (67)
 
46.3% (1603)
40.4% (182)
 
46.8% (1718)
1
33.3% (1070)
33.9% (83)
 
33.3% (1153)
36.4% (164)
 
33.6% (1234)
2
12.1% (389)
20.4% (50)
 
12.7% (439)
12.2% (55)
 
12.1% (444)
3
3.6% (115)
9.0% (22)
 
4.0% (137)
6.7% (30)
 
4.0% (145)
4 or more
3.4% (108)
9.4% (23)
 
3.8% (131)
4.2% (19)
 
3.5% (127)
Total
100% (3218)
100% (245)
 
100% (3463)
100% (450)
 
100% (3668)
Symptomatic at diagnosis
  
< 0.001*
  
0.713
 
No
48.9% (1555)
31.8% (76)
 
47.7% (1631)
47.9% (214)
 
48.8% (1769)
Yes
51.1% (1623)
68.2% (163)
 
52.3% (1786)
52.1% (233)
 
51.2% (1856)
Total
100% (3178)
100% (239)
 
100% (3417)
100% (447)
 
100% (3625)
Overall urinary symptoms
  
< 0.001*
  
0.831
 
No/very small/small problem
89.4% (2868)
69.0% (167)
 
88.0% (3035)
89.9% (400)
 
89.5% (3268)
Moderate/big problem
10.6% (339)
31.0% (75)
 
12.0% (414)
10.1% (45)
 
10.5% (384)
Total
100% (3207)
100% (242)
 
100% (3449)
100% (445)
 
100% (3652)
Overall bowel symptoms
  
< 0.001*
  
0.614
 
No/very small/small problem
94.7% (3034)
77.3% (187)
 
93.4% (3221)
94.0% (420)
 
94.6% (3454)
Moderate/big problem
5.3% (171)
22.7% (55)
 
6.6% (226)
6.0% (27)
 
5.4% (198)
Total
100% (3205)
100% (242)
 
100% (3447)
100% (447)
 
100% (3652)
BMI
  
< 0.001*
  
0.092
 
< 25 kg/m2
26.7% (810)
21% (47)
 
26.3% (857)
30% (131)
 
27.1% (941)
25–29.9 kg/m2
48% (1459)
40.2% (90)
 
47.5% (1549)
49.1% (214)
 
48.1% (1673)
≥ 30 kg/m2
25.3% (770)
38.8% (87)
 
26.3% (857)
20.9% (91)
 
24.8% (861)
Total
100% (3039)
100% (224)
 
100% (3263)
100% (436)
 
100% (3475)
Employment type
  
0.029
  
< 0.001*
 
Full time
72.3% (2327)
73.1% (179)
 
72.4% (2506)
77.8% (350)
 
73% (2677)
Part time
5.4% (174)
9% (22)
 
5.7% (196)
10.7% (48)
 
6.1% (222)
Self-employed
22.3% (717)
18% (44)
 
22% (761)
11.6% (52)
 
21% (769)
Total
100% (3218)
100% (245)
 
100% (3463)
100% (450)
 
100% (3668)
Seen HC professional for mental health issues
  
< 0.001*
  
0.183
 
Yes
22% (700)
33.7% (82)
 
22.8% (782)
24.8% (111)
 
22.3% (811)
No
78% (2489)
66.3% (161)
 
77.2% (2650)
75.2% (337)
 
77.7% (2826)
Total
100% (3189)
100% (243)
 
100% (3432)
100% (448)
 
100% (3637)
Caring responsibilities
  
0.875
  
0.003*
 
Yes
22.3% (707)
22.9% (55)
 
22.3% (762)
28.7% (127)
 
23% (834)
No
77.7% (2470)
77.1% (185)
 
77.7% (2655)
71.3% (316)
 
77% (2786)
Total
100% (3177)
100% (240)
 
100% (3417)
100% (443)
 
100% (3620)
EBRT external beam radiotherapy, ADT androgen deprivation therapy
*Significant at p < 0.05 after Bonferroni adjustment for multiple comparisons
Ever seen a healthcare professional for problems with emotions or nerves or use of alcohol or drugs

Men becoming unemployed

There was no difference in the proportion of EtoU men aged 56–60 years (60.0%) compared to EtoE men (55.9%) (p = 0.29) (Table 2). Univariable analysis demonstrated there were greater proportions of men who became unemployed who were divorced, from deprived areas, from Scotland or NI, with late stage disease at diagnosis, symptomatic at diagnosis, with more comorbidities and reporting moderate or big problems with urinary and bowel function (Table 2). There was no difference in ethnicity between EtoE and EtoU groups (Table 2). A lower proportion of EtoU men had surgery and experienced active surveillance, but a greater proportion had external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT).
Multivariable logistic regression demonstrated a range of sociodemographic, clinical and patient-reported factors were predictive of movement from employment at diagnosis to unemployment at follow-up (i.e. comparing EtoU to EtoE groups) (Table 3). Late stage at diagnosis (OR = 4.7 (95% CI 3.1–7.0), stage IV relative to stage I/II) and greater comorbidity (OR ranging from OR 1.6 (95% CI 1.1–2.3) for 1 LTC to 3.5 (95% CI 1.8–6.8) for ≥ 4 LTCs compared to none) were the strongest predictors of movement to unemployment. Problems with bowel (OR = 2.5 (95% CI 1.6–3.9) moderate/big compared to no/very small/small problems) and urinary function (OR = 2.0 (95% CI 1.4–2.9) moderate/big compared to no/very small/small problems) and having symptoms at diagnosis (OR = 1.5 (95% CI 1.0–2.1)) were also predictors of movement to unemployment (Table 3). Living in areas of greater deprivation (OR = 2.6 (95% CI 1.6–4.3] most relative to least deprived), being divorced/separated (OR = 2.5 (95% CI 1.7–3.8]) and living in Scotland (OR = 2.1 (95% CI 1.2–3.6]) or NI (OR = 3.1 (95% CI 1.7–5.6] compared to living in England) were also significant predictors of becoming unemployed.
Table 3
Significant independent predictors of movement between employment and unemployment for men aged 60 years and below using logistic regression modelling
 
Odds ratio
95% CI lower
95% CI upper
p value
Deprivation
 
 Q1 (area of least deprivation)
1.00
   
 Q2
0.87
0.50
1.50
0.618
 Q3
1.57
0.93
2.63
0.090
 Q4
1.92
1.16
3.19
0.011*
 Q5 (area of greatest deprivation)
2.58
1.56
4.26
< 0.001*
Marital status
 
 Married/civil partnership
1.00
   
 Divorced/separated
2.50
1.65
3.80
< 0.001*
 Widowed
1.58
0.51
4.93
0.42
 Single
1.51
0.80
2.87
0.205
 Other
1.29
0.52
3.16
0.580
UK country
 
 England
1.00
   
 Wales
1.08
0.57
2.05
0.811
 Scotland
2.08
1.20
3.61
0.009*
 Northern Ireland
3.11
1.71
5.64
< 0.001*
Stage
 
 Stage I/II
1.00
   
 Stage III
1.72
1.17
2.53
0.006*
 Stage IV
4.68
3.11
7.03
< 0.001*
Symptomatic at diagnosis
 
 No
1.00
   
 Yes
1.47
1.04
2.06
0.028*
Comorbidities
 
 No comorbidities
1.00
   
 1 comorbidity
1.57
1.07
2.32
0.023
 2 comorbidities
2.27
1.44
3.57
< 0.001*
 3 comorbidities
2.47
1.30
4.68
0.006*
 4 or more comorbidities
3.49
1.80
6.79
< 0.001*
Bowel symptoms (overall)
 
 No/very small/small problems
1.00
   
 Moderate/big problems
2.54
1.64
3.94
< 0.001*
Urinary symptoms (overall)
 
 No/very small/small problems
1.00
   
 Moderate/big problems
2.02
1.37
2.97
< 0.001*
Factors contributing significantly to the model (p < 0.05) are reported. Variables included in the model were age, relationship status, deprivation quintile, UK country of residence, ethnicity, BMI, type of employment at diagnosis, stage at diagnosis, whether symptomatic at diagnosis, whether had PSA testing at diagnosis, comorbidities, overall urinary problems, overall bowel problems, having ever seen a professional for mental health issues and caring responsibilities

Men retiring early

In the univariable analysis, there were no differences in disease stage at diagnosis or the proportions who were symptomatic at diagnosis between men retiring early and those who remained in employment (Table 2). There were no differences in treatment type or overall urinary or bowel function between the EtoR and EtoE group. Men remaining in employment were significantly younger (mean age = 55.4 years, p < 0.001) than those retiring early (mean age = 57.7 years), with a difference of over 2 years between the groups. There was a greater proportion of older men in the EtoR group with 83.1% aged 56–60 years compared to 55.9% in the EtoE group (Table 2). There were greater proportions of EtoR relative to EtoE men of white ethnicity, from less-deprived areas and with caring responsibility and lower proportions of EtoR compared to EtoE men living in England and reporting no comorbidities (Table 2).
In the multivariable analysis, age, ethnicity, employment status, UK country of residence, stage at diagnosis and carer responsibilities were significantly associated with moving from employment to retirement (Table 4). Older age was the strongest predictor of early retirement (OR 8.5 (95% CI 4.0–18.3), age 55–60 years). Men living in NI (OR = 2.3 (95% CI 1.4–3.6)), with later disease stage disease (OR = 1.8 (95% CI 1.2–2.6), stage IV) and carer responsibilities (OR = 1.3 (95% CI 1.0–1.7)) were also significantly more likely to move to early retirement. Men who were self-employed (OR = 0.40 (95% CI 0.28–0.57)) and of non-white ethnicity (OR = 0.32 (95% CI 0.16–0.63)) were significantly less likely to move to early retirement.
Table 4
Significant independent predictors of movement between employment and retirement for men aged 60 years and below using logistic regression modelling
 
Odds ratio
95% CI lower
95% CI upper
p value
Age band
 
 < 50 years
1.00
   
 50–54 years
2.57
1.16
5.71
0.021
 55–60 years
8.52
3.97
18.28
< 0.001*
Ethnicity (reference)
 
 White
1.00
   
 Non-white
0.32
0.16
0.63
0.001*
Employment type
 
 Full-time employment
1.00
   
 Part-time employment
1.38
0.94
2.03
0.099
 Self-employed
0.40
0.28
0.57
< 0.001*
UK country
 
 England
1.00
   
 Wales
1.25
0.83
1.87
0.281
 Scotland
0.67
0.36
1.25
0.208
 Northern Ireland
2.29
1.44
3.64
< 0.001*
Stage
 
 Stage I/ II
1.00
   
 Stage III
0.99
0.75
1.31
0.934
 Stage IV
1.79
1.22
2.62
0.003*
Carer responsibilities
 
 No
1.00
   
 Yes
1.29
1.00
1.66
0.050*
Factors contributing significantly to the model (p < 0.05) are reported. Variables included in the model were age, relationship status, deprivation quintile, UK country of residence, ethnicity, BMI, type of employment at diagnosis, stage at diagnosis, comorbidities, overall urinary problems, overall bowel problems, having ever seen a professional for mental health issues and caring responsibilities

Discussion

The clinical factors of advanced disease stage, presence of bowel and urinary problems, having symptoms at diagnosis and greater levels of comorbidity increased the odds of job loss in PCa survivors, alongside the sociodemographic factors of deprivation, divorce/separation and living in Scotland or NI. In contrast, having bowel or urinary problems or greater comorbidity were not significantly associated with early retirement in PCa survivors. Men who were older, of white ethnicity, in full-time employment, with most advanced disease (stage IV) or with caring responsibilities had greater odds of early retirement.

Movement to unemployment

In our study, advanced disease stage at diagnosis was the strongest predictor of becoming unemployed, with the odds of men with stage IV disease becoming unemployed almost five times those of men with stage I/II disease. Problems with bowel and urinary function were also strong predictors of becoming unemployed. This suggests that more severe disease and treatment side effects adversely impact on employment. Previous studies of cancer survivors report associations between both cancer severity and adverse effects and delayed returning to work [20]. However, those involving PCa survivors report variable associations between clinical factors and employment status, productivity and work engagement [2124]. However, these studies were not population based, involved small numbers of PCa survivors (n < 180) and were non-UK based. More severe bowel symptoms have, for example, been associated with greater number of missed workdays in irritable bowel syndrome (IBS) sufferers [25], who have been reported to experience significant work impairment with substantial productivity and cost implications [26, 27]. Comorbidity was also a significant predictor of becoming unemployed with the likelihood of job loss increasing with the number of comorbidities. Greater comorbidity has been associated with reduced work ability in Nordic PCa survivors [28], but greater disability was not associated with higher job quitting rates in a US study of PCa survivors [29].
We have identified sociodemographic factors that predict job loss. Men living in the most deprived areas had over twice the odds of becoming unemployed. A study reporting on 100 PCa survivors in Ireland found more socioeconomically deprived men were less likely to resume work following diagnosis [10]. A possible reason may have been difficulty maintaining physically demanding or manual jobs, which are more common in men in deprived areas [30]. Cancer survivors with physically demanding jobs, such as heavy lifting, found their jobs more challenging [31, 32], and manual labour was found to negatively impact on survivors return-to-work [33]. As men from more deprived areas may have more physically demanding or manual jobs this may have been a possible reason for their higher odds of unemployment. Divorced or separated men had 2.5 times greater odds of becoming unemployed compared to married men. Men living in NI and Scotland were over twice as likely to become unemployed as English men, which broadly reflect unemployment patterns between 2013 and 2016 in which, against a background downward trend in all UK countries, unemployment rates in NI and Scotland were slightly higher than the UK average [34].

Early retirement

Our findings for men who moved from employment to early retirement were very different, and men with more severe urinary and bowel problems or a greater number of comorbidities were not more likely to retire early. Older age was the strongest predictor of early retirement with the odds of retiring early for men aged 55–60 years almost nine times greater than that of men less than 50 years old, although numbers in the reference category (< 50 years) were small (N = 20). It is not surprising that older men were more likely to retire than younger men in this study. However, older men were not more likely to be become unemployed, with no significant relationship between age and movement to unemployment on logistic regression analysis.
Those of non-white ethnicity were significantly less likely to retire early, although numbers in this group were small. Male ethnic minorities in the UK experience higher rates of unemployment [35] and have, on average, lower income than the white population [36], with earning differentials at least 10% less than comparable white men [37]. Consequently, white UK men may be more economically able to support themselves and their families in retirement at an earlier age. Employment type (e.g. full-time, part-time, self-employed) predicted move to early retirement, but not to unemployment. The odds of self-employed men moving to early retirement were 60% less than men in full-time employment, which supports the finding of Sharp et al. that self-employed PCa survivors were more likely to continue working following diagnosis [10].
The findings from the present study suggest that men who became unemployed and those who retired early following PCa diagnosis represent very different groups. Compared with men who remain in employment, those who become unemployed had different socioeconomic characteristics, more severe disease and worse clinical symptoms. In contrast, the sociodemographic profile and symptom characteristics of men who retire early was similar to men who continue to work. Men with PCa who retired early had no worse urinary or bowel symptoms than those who remain in employment. They were less likely to be self-employed and not more deprived. However, they are more likely to have caring responsibilities, suggesting this may be a possible reason for retiring early. Although it is unsurprising that those from more deprived areas had greater odds of becoming unemployed and those from less-deprived areas had greater odds of retiring early, there are few studies which consider factors associated with change in employment status of cancer survivors following diagnosis (i.e. moving from employment to either unemployment or early retirement compared to those who stay in employment) and none involving a population-based study of prostate cancer survivors.

Practical implications

This study has identified characteristics associated with job loss and early retirement, which can be used by health and social care staff, employers and human resources staff to target information, advice and support for PCa survivors to mitigate work impairment and support return to work. Local networks integrated with existing care systems have been suggested as a model, which can support urological cancer survivors who wish to stay in employment [38] and workplace counselling [39], workplace evaluation [40] and workplace rehabilitation [41] may help sustain cancer survivors in employment. Ideally, PCa survivors at risk of unemployment would be empowered to actively seek assistance, which could maintain employment.
Factors associated with employment outcomes for cancer survivors include health and well-being, symptom control and function as well as work demands, work environment and policies and economic factors [42]. Our study found that men with worse urinary and bowel symptoms had greater odds of becoming unemployed. Men with a greater number of comorbidities, and likely poorer function, also had greater odds of losing their job. Men who were divorced/separated or living in deprived areas also had greater odds of losing their job. Targeted support to maintain employment may be warranted for PCa survivors who are, for example, divorced or separated, from more deprived backgrounds and with a number of comorbidities, especially those experiencing urinary or bowel symptoms following treatment. This study will also help inform future research into maintaining employment following PCa diagnosis. Such research could focus on disease-specific symptoms and general health status alongside social and demographic factors, ideally in longitudinal studies which would also consider work-related factors.

Limitations

Although this is the first study to investigate a range of sociodemographic, clinical and patient-reported factors associated with movement from employment at time of PCa diagnosis to unemployment or early retirement in a large-scale UK population-based study, there were a number of limitations. We did not have details of when men became unemployed, of income, pension or educational levels or of work-related factors, such as type of occupation (e.g. service and manufacturing) and hours worked, which may have been associated with movement to unemployment or early retirement. Although we report significant associations with movement to unemployment or early retirement, we cannot assume causal relationships. We acknowledge that some of the observed movement to early retirement may have occurred independent of PCa diagnosis. We compared both EtoU and EtoR groups with recently diagnosed PCa survivors who were employed both at diagnosis and follow-up (EtoE group) and assumed these men remained in employment during that period. Some variables had low numbers in sub-categories (e.g. those of non-white ethnicity who retired early, N = 11) which warrant caution in interpretation. However, these were in the context of large category numbers (e.g. 261 men of non-white ethnicity in the sample) and overall group numbers (3218 in EtoE, 245 in EtoU and 450 in the EtoR groups) which were much greater than previous studies of job loss and early retirement involving PCa survivors.

Conclusion

Men who retire early following PCa diagnosis do not report worse overall urinary or bowel problems or different socioeconomic characteristics to men remaining in employment. However, this study has identified risk factors for job loss in PCa survivors, which can be used to support men following diagnosis. Targeted support and engagement with these men, their families and their employers is needed.

Acknowledgements

The authors thank all the men who completed the surveys. The authors acknowledge the following people for their contribution to the development, setting up and running of the study: Heather Kinnear, Victoria Cairnduff, Oonagh McSorley, Conan Donnelly, Linda Roberts, Rebecca Mottram, Majorie Allen, Adrian Slater, the LAPCD User Advisory Group and Clinical & Scientific Advisory Group, Picker Institute Europe and Business Services Organisation (NI). This study is based in part on information collected and quality assured by the cancer registries in each nation. This work uses data provided by patents and collected by health services as part of their care and support.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

The study received the following ethical approvals: Newcastle & North Tyneside 1 Research Ethics Committee (15/NE/0036), Confidentiality Advisory Group (15/CAG/0110), NHS Scotland Public Benefit and Privacy Panel (0516–0364), Office of Research Ethics Northern Ireland (16/NI/0073) and NHS R&D approval from Wales, Scotland, and Northern Ireland. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Anhänge

Electronic supplementary material

Literatur
1.
Zurück zum Zitat Cancer Research UK. Cancer survival statistics [Internet]. 2017 [cited 2017 Sep 28]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/survival. Cancer Research UK. Cancer survival statistics [Internet]. 2017 [cited 2017 Sep 28]. Available from: http://​www.​cancerresearchuk​.​org/​health-professional/​cancer-statistics/​survival.​
3.
Zurück zum Zitat Cancer Research UK. Prostate cancer incidence statistics [internet]. 2017. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence#ref-2. Cancer Research UK. Prostate cancer incidence statistics [internet]. 2017. Available from: http://​www.​cancerresearchuk​.​org/​health-professional/​cancer-statistics/​statistics-by-cancer-type/​prostate-cancer/​incidence#ref-2.
4.
Zurück zum Zitat Macmillan, Public Health England. The Macmillan-NCRAS Work Plan: The UK Cancer Prevalence Project [Internet]. 2017 [cited 2018 Jan 19]. Available from: http://www.ncin.org.uk/about_ncin/segmentation. Macmillan, Public Health England. The Macmillan-NCRAS Work Plan: The UK Cancer Prevalence Project [Internet]. 2017 [cited 2018 Jan 19]. Available from: http://​www.​ncin.​org.​uk/​about_​ncin/​segmentation.​
6.
Zurück zum Zitat Macmillan. Work and cancer [Internet]. 2016. Available from: https://www.macmillan.org.uk/information-and-support/organising/work-and-cancer/information-for-employees/index.html. Macmillan. Work and cancer [Internet]. 2016. Available from: https://​www.​macmillan.​org.​uk/​information-and-support/​organising/​work-and-cancer/​information-for-employees/​index.​html.​
7.
Zurück zum Zitat Handberg C, Nielsen CV, Lomborg K. Men’s reflections on participating in cancer rehabilitation: a systematic review of qualitative studies 2000–2013. Eur J Cancer Care (Engl). 2014;23:159–72.CrossRef Handberg C, Nielsen CV, Lomborg K. Men’s reflections on participating in cancer rehabilitation: a systematic review of qualitative studies 2000–2013. Eur J Cancer Care (Engl). 2014;23:159–72.CrossRef
8.
Zurück zum Zitat Handberg C, Lomborg K, Nielsen C, Oliffe JL, Midtgard J. Understanding male cancer patients’ barriers to participating in cancer rehabilitation. Eur J Cancer Care (Engl). 2015;801–11.CrossRefPubMed Handberg C, Lomborg K, Nielsen C, Oliffe JL, Midtgard J. Understanding male cancer patients’ barriers to participating in cancer rehabilitation. Eur J Cancer Care (Engl). 2015;801–11.CrossRefPubMed
9.
Zurück zum Zitat Soejima T, Kamibeppu K. Are cancer survivors well-performing workers? A systematic review. Asia Pacific J Clin Oncol. 2016;12:383–97.CrossRef Soejima T, Kamibeppu K. Are cancer survivors well-performing workers? A systematic review. Asia Pacific J Clin Oncol. 2016;12:383–97.CrossRef
10.
Zurück zum Zitat Sharp L, Timmons A. Social welfare and legal constraints associated with work among breast and prostate cancer survivors: experiences from Ireland. J Cancer Surviv. 2011;5:382–94.CrossRefPubMed Sharp L, Timmons A. Social welfare and legal constraints associated with work among breast and prostate cancer survivors: experiences from Ireland. J Cancer Surviv. 2011;5:382–94.CrossRefPubMed
11.
Zurück zum Zitat Downing A, Wright P, Wagland R, Watson E, Kearney T, Mottram R, et al. Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study. BMJ Open. 2016;6:e013555. Available from: http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2016-013555CrossRefPubMedPubMedCentral Downing A, Wright P, Wagland R, Watson E, Kearney T, Mottram R, et al. Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study. BMJ Open. 2016;6:e013555. Available from: http://​bmjopen.​bmj.​com/​lookup/​doi/​10.​1136/​bmjopen-2016-013555CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Office for National Statistics. Average age of retirement rises as people work longer [Internet]. 2012. Available from: http://webarchive.nationalarchives.gov.uk/20160112154633/http://www.ons.gov.uk/ons/rel/mro/news-release/average-age-of-retirement-rises-as-people-work-longer/index.html. Office for National Statistics. Average age of retirement rises as people work longer [Internet]. 2012. Available from: http://​webarchive.​nationalarchives​.​gov.​uk/​20160112154633/​http://www.ons.gov.uk/ons/rel/mro/news-release/average-age-of-retirement-rises-as-people-work-longer/index.html.
18.
Zurück zum Zitat Greve J. Obesity and labor market outcomes in Denmark. Econ Hum Biol [Internet]. 2008;6:350–62. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1570677X08000610CrossRef Greve J. Obesity and labor market outcomes in Denmark. Econ Hum Biol [Internet]. 2008;6:350–62. Available from: http://​linkinghub.​elsevier.​com/​retrieve/​pii/​S1570677X0800061​0CrossRef
19.
Zurück zum Zitat Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899–905. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11113727CrossRefPubMed Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899–905. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​11113727CrossRefPubMed
20.
Zurück zum Zitat Marino P, Luis Sagaon T, Laetitia M, Anne-Gaelle LC-S. Sex differences in the return-to-work process of Cancer survivors 2 years after diagnosis: results from a large French population-based sample. J Clin Oncol. 2013;31:1277–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23358985CrossRefPubMed Marino P, Luis Sagaon T, Laetitia M, Anne-Gaelle LC-S. Sex differences in the return-to-work process of Cancer survivors 2 years after diagnosis: results from a large French population-based sample. J Clin Oncol. 2013;31:1277–84. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​23358985CrossRefPubMed
21.
Zurück zum Zitat Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national Sample. J Natl Cancer Inst. 2004;96:1322–30.CrossRefPubMed Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national Sample. J Natl Cancer Inst. 2004;96:1322–30.CrossRefPubMed
22.
Zurück zum Zitat Bradley CJ, Neumark D, Luo Z, Bednarek H, Schenk M. Employment outcomes of men treated for prostate cancer. JNCI J Natl Cancer Inst. 2005;97:958–65. [cited 2017 Sep 5] Available from: http://www.ncbi.nlm.nih.gov/pubmed/15998948CrossRefPubMed Bradley CJ, Neumark D, Luo Z, Bednarek H, Schenk M. Employment outcomes of men treated for prostate cancer. JNCI J Natl Cancer Inst. 2005;97:958–65. [cited 2017 Sep 5] Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​15998948CrossRefPubMed
23.
Zurück zum Zitat Berg Gudbergsson S, Fosså SD, Dahl AA. Is cancer survivorship associated with reduced work engagement? A NOCWO Study. J Cancer Surviv. 2008;2:159–68. [cited 2017 Sep 5] Available from: http://www.ncbi.nlm.nih.gov/pubmed/18654861CrossRefPubMed Berg Gudbergsson S, Fosså SD, Dahl AA. Is cancer survivorship associated with reduced work engagement? A NOCWO Study. J Cancer Surviv. 2008;2:159–68. [cited 2017 Sep 5] Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​18654861CrossRefPubMed
24.
Zurück zum Zitat Norredam M, Meara E, Landrum MB, Huskamp HA, Keating NL. Financial status, employment, and insurance among older cancer survivors. J Gen Intern Med. 2009;24:438–45.CrossRefPubMedCentral Norredam M, Meara E, Landrum MB, Huskamp HA, Keating NL. Financial status, employment, and insurance among older cancer survivors. J Gen Intern Med. 2009;24:438–45.CrossRefPubMedCentral
25.
Zurück zum Zitat Hahn BA, Oerfer LJK, On SF, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms , health resource utilization and quality of life. Aliment Pharmacol Ther. 1997;11:553–9.CrossRefPubMed Hahn BA, Oerfer LJK, On SF, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms , health resource utilization and quality of life. Aliment Pharmacol Ther. 1997;11:553–9.CrossRefPubMed
26.
Zurück zum Zitat Hahn B, Yan S, Strassles S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion. 1999;60:77–81.CrossRefPubMed Hahn B, Yan S, Strassles S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion. 1999;60:77–81.CrossRefPubMed
27.
Zurück zum Zitat Buono JL, Carson RT, Flores NM. Health-related quality of life, work productivity , and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes. 2017;15:1–8.CrossRef Buono JL, Carson RT, Flores NM. Health-related quality of life, work productivity , and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes. 2017;15:1–8.CrossRef
28.
Zurück zum Zitat Lindbohm M-L, Taskila T, Kuosma E, Hietanen P, Carlsen K, Gudbergsson S, et al. Work ability of survivors of breast, prostate, and testicular cancer in Nordic countries: a NOCWO study. J Cancer Surviv. 2012;6:72–81. [cited 2017 Sep 7] Available from: http://www.ncbi.nlm.nih.gov/pubmed/22042662CrossRefPubMed Lindbohm M-L, Taskila T, Kuosma E, Hietanen P, Carlsen K, Gudbergsson S, et al. Work ability of survivors of breast, prostate, and testicular cancer in Nordic countries: a NOCWO study. J Cancer Surviv. 2012;6:72–81. [cited 2017 Sep 7] Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​22042662CrossRefPubMed
29.
Zurück zum Zitat Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103(6):1292–301.CrossRefPubMed Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103(6):1292–301.CrossRefPubMed
30.
Zurück zum Zitat Lakshman R, McConville A, How S, Flowers J, Wareham N, Cosford P. Association between area-level socioeconomic deprivation and a cluster of behavioural risk factors: cross-sectional, population-based study. J Public Health (Bangkok). 2011;33:234–45.CrossRef Lakshman R, McConville A, How S, Flowers J, Wareham N, Cosford P. Association between area-level socioeconomic deprivation and a cluster of behavioural risk factors: cross-sectional, population-based study. J Public Health (Bangkok). 2011;33:234–45.CrossRef
31.
Zurück zum Zitat Taskila T, Martikainen R, Hietanen P, Lindbohm M-L. Comparative study of work ability between cancer survivors and their referents. Eur J Cancer. 2007;43:914–20. [cited 2017 Sep 5] Available from: http://www.ncbi.nlm.nih.gov/pubmed/17314041CrossRefPubMed Taskila T, Martikainen R, Hietanen P, Lindbohm M-L. Comparative study of work ability between cancer survivors and their referents. Eur J Cancer. 2007;43:914–20. [cited 2017 Sep 5] Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​17314041CrossRefPubMed
32.
Zurück zum Zitat de Jong M, Tamminga SJ, Frings-Dresen MHW, de Boer AGEM. Quality of working life of cancer survivors: associations with health- and work-related variables. Support Care Cancer. 2017;25:1475–84.CrossRefPubMed de Jong M, Tamminga SJ, Frings-Dresen MHW, de Boer AGEM. Quality of working life of cancer survivors: associations with health- and work-related variables. Support Care Cancer. 2017;25:1475–84.CrossRefPubMed
33.
Zurück zum Zitat Spelten ER, Sprangers MAG, Verbeek JHAM. Factors reported to influence the return to work of cancer survivors: a literature review. Psychooncology. 2002;11:124–31.CrossRefPubMed Spelten ER, Sprangers MAG, Verbeek JHAM. Factors reported to influence the return to work of cancer survivors: a literature review. Psychooncology. 2002;11:124–31.CrossRefPubMed
37.
Zurück zum Zitat Clark K, Drinkwater S. Ethnic minorities in the labour market [internet]. Joseph Rowntree Foundation 2007. Available from: http://www.cabinetoffice.gov.uk/media/cabinetoffice/strategy/assets/heathdata.pdf. Clark K, Drinkwater S. Ethnic minorities in the labour market [internet]. Joseph Rowntree Foundation 2007. Available from: http://​www.​cabinetoffice.​gov.​uk/​media/​cabinetoffice/​strategy/​assets/​heathdata.​pdf.​
38.
Zurück zum Zitat Maclennan SJ, Lecturer S, Cox T, Murdoch SE. Changing current practice in urological cancer care: providing better information, advice and related support on work engagement. Eur J Cancer Care (Engl). 2017;26:1–10.CrossRef Maclennan SJ, Lecturer S, Cox T, Murdoch SE. Changing current practice in urological cancer care: providing better information, advice and related support on work engagement. Eur J Cancer Care (Engl). 2017;26:1–10.CrossRef
39.
Zurück zum Zitat Gudbergsson SB, Torp S, Fløtten T, Fosså SD, Dahl AA, Berg S, et al. A comparative study of cancer patients with short and long sick-leave after primary treatment. Acta Oncol (Madr). 2011;50:381–9.CrossRef Gudbergsson SB, Torp S, Fløtten T, Fosså SD, Dahl AA, Berg S, et al. A comparative study of cancer patients with short and long sick-leave after primary treatment. Acta Oncol (Madr). 2011;50:381–9.CrossRef
40.
Zurück zum Zitat Beresford SAA, Locke E, Bishop S, West B, McGregor BA, Bruemmer B, et al. Worksite study promoting activity and changes in eating (PACE): design and baseline results. Obesity. 2007;15:4S–15S.CrossRefPubMed Beresford SAA, Locke E, Bishop S, West B, McGregor BA, Bruemmer B, et al. Worksite study promoting activity and changes in eating (PACE): design and baseline results. Obesity. 2007;15:4S–15S.CrossRefPubMed
41.
Zurück zum Zitat de Boer A, Taskila T, Ojajärvi A, van Dijk FJH, Verbeek J. Cancer survivors and unemployment—a meta-analysis and meta-regression. JAMA. 2009; 301(7):753–62.CrossRefPubMed de Boer A, Taskila T, Ojajärvi A, van Dijk FJH, Verbeek J. Cancer survivors and unemployment—a meta-analysis and meta-regression. JAMA. 2009; 301(7):753–62.CrossRefPubMed
42.
Zurück zum Zitat Feuerstein M, Todd BL, Moskowitz MC, Bruns GL. Work in cancer survivors: a model for practice and research. J Cancer Surviv. 2010;4:415–37.CrossRefPubMed Feuerstein M, Todd BL, Moskowitz MC, Bruns GL. Work in cancer survivors: a model for practice and research. J Cancer Surviv. 2010;4:415–37.CrossRefPubMed
Metadaten
Titel
Factors influencing job loss and early retirement in working men with prostate cancer—findings from the population-based Life After Prostate Cancer Diagnosis (LAPCD) study
verfasst von
Damien Bennett
Therese Kearney
David W. Donnelly
Amy Downing
Penny Wright
Sarah Wilding
Richard Wagland
Eila Watson
Adam Glaser
Anna Gavin
Publikationsdatum
30.07.2018
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 5/2018
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-018-0704-x

Weitere Artikel der Ausgabe 5/2018

Journal of Cancer Survivorship 5/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.